ROHTO PHARMACEUTICAL CO.,LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,990 JPY | +2.34% |
|
+3.67% | +5.24% |
| Apr. 04 | Rohto Pharmaceutical Eyes MGO on Singapore's Eu Yan Sang International for 88 Billion Yen | MT |
| Apr. 04 | Rohto Pharmaceutical, Mitsui & Co. to Acquire Singapore-Based Eu Yan Sang -- Update | DJ |
Evolution of the average Target Price on Rohto Pharmaceutical Co.,Ltd.
Price target over the last 5 years
History of analyst recommendation changes
f8aea6864a948a.rX-1QQVH5A3UvpRB6Tp_-CuL6YLdfOtax5tNM1YOpis.yk_5DDUX0Hi4_aQu3lg3nx7DvvapFJwpk-wrARF49lHeGt8JQ3eJZpCN0Q~5050cafadae412dc21412d615a376f6e
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
2,922
JPY
Average target price
3,892
JPY
Spread / Average Target
+33.21%
High Price Target
4,500
JPY
Spread / Highest target
+54.00%
Low Price Target
3,370
JPY
Spread / Lowest Target
+15.33%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- 4527 Stock
- Consensus Rohto Pharmaceutical Co.,Ltd.
